Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 2/2023

25.10.2022 | Original Article

[18F]-FDG PET and MRI radiomic signatures to predict the risk and the location of tumor recurrence after re-irradiation in head and neck cancer

verfasst von: Arnaud Beddok, Fanny Orlhac, Valentin Calugaru, Laurence Champion, Catherine Ala Eddine, Christophe Nioche, Gilles Créhange, Irène Buvat

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate whether radiomics from [18F]-FDG PET and/or MRI before re-irradiation (reRT) of recurrent head and neck cancer (HNC) could predict the occurrence and the location “in-field” or “outside” of a second locoregional recurrence (LR).

Methods

Among the 55 patients re-irradiated at curative intend for HNC from 2012 to 2019, 48 had an MRI and/or PET before the start of the reRT. Thirty-nine radiomic features (RF) were extracted from the re-irradiated GTV (rGTV) using LIFEx software. Student t tests and Spearman correlation coefficient were used to select the RF that best separate patients who recurred from those who did not, and “in-field” from “outside” recurrences. Principal component analysis involving these features only was used to create a prediction model. Leave-one-out cross-validation was performed to evaluate the models.

Results

After a median follow-up of 17 months, 40/55 patients had developed a second LR, including 18 “in-field” and 22 “outside” recurrences. From pre-reRT MRI, a model based on three RF (GLSZM_SZHGLE, GLSZM_LGLZE, and skewness) predicted whether patients would recur with a balanced accuracy (BA) of 83.5%. Another model from pre-reRT MRI based on three other RF (GLSZM_ LZHGE, NGLDM_Busyness, and GLZLM_SZE) predicted whether patients would recur “in-field” or “outside” with a BA of 78.5%. From pre-reRT PET, a model based on four RF (Kurtosis, SUVbwmin, GLCM_Correlation, and GLCM_Contrast) predicted the LR location with a BA of 84.5%.

Conclusion

RF characterizing tumor heterogeneity extracted from pre-reRT PET and MRI predicted whether patients would recur, and whether they would recur “in-field” or “outside”.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Tao Y, Aupérin A, Sun X, Sire C, Martin L, Coutte A, et al. Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: the safety phase of a randomised phase III trial GORTEC 2017–01 (REACH). Eur J Cancer. 2020;141:21–9.CrossRef Tao Y, Aupérin A, Sun X, Sire C, Martin L, Coutte A, et al. Avelumab-cetuximab-radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: the safety phase of a randomised phase III trial GORTEC 2017–01 (REACH). Eur J Cancer. 2020;141:21–9.CrossRef
2.
Zurück zum Zitat Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84:1198–205.CrossRef Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012;84:1198–205.CrossRef
3.
Zurück zum Zitat Setton J, Caria N, Romanyshyn J, Koutcher L, Wolden SL, Zelefsky MJ, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center Experience. Int J Radiat Oncol* Biol* Phys. 2012;82:291–8.CrossRef Setton J, Caria N, Romanyshyn J, Koutcher L, Wolden SL, Zelefsky MJ, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center Experience. Int J Radiat Oncol* Biol* Phys. 2012;82:291–8.CrossRef
4.
Zurück zum Zitat Nichols AC, Kneuertz PJ, Deschler DG, Lin DT, Emerick KS, Clark JR, et al. Surgical salvage of the oropharynx after failure of organ-sparing therapy. Head Neck. 2011;33:516–24.CrossRef Nichols AC, Kneuertz PJ, Deschler DG, Lin DT, Emerick KS, Clark JR, et al. Surgical salvage of the oropharynx after failure of organ-sparing therapy. Head Neck. 2011;33:516–24.CrossRef
5.
Zurück zum Zitat Bachar GY, Goh C, Goldstein DP, O’Sullivan B, Irish JC. Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy. Eur Arch Otorhinolaryngol. 2009;267:295.CrossRef Bachar GY, Goh C, Goldstein DP, O’Sullivan B, Irish JC. Long-term outcome analysis after surgical salvage for recurrent tonsil carcinoma following radical radiotherapy. Eur Arch Otorhinolaryngol. 2009;267:295.CrossRef
6.
Zurück zum Zitat Taussky D, Dulguerov P, Allal AS. Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas. Head Neck. 2005;27:182–6.CrossRef Taussky D, Dulguerov P, Allal AS. Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas. Head Neck. 2005;27:182–6.CrossRef
7.
Zurück zum Zitat Lee J, Shin I-S, Kim WC, Yoon WS, Koom WS, Rim CH. Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: meta-analysis and systematic review. Head Neck. 2020;42:2473–85.CrossRef Lee J, Shin I-S, Kim WC, Yoon WS, Koom WS, Rim CH. Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: meta-analysis and systematic review. Head Neck. 2020;42:2473–85.CrossRef
8.
Zurück zum Zitat Margalit DN, Rawal B, Catalano PJ, Haddad RI, Goguen LA, Annino DJ, et al. Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences. Oral Oncol. 2016;61:19–26.CrossRef Margalit DN, Rawal B, Catalano PJ, Haddad RI, Goguen LA, Annino DJ, et al. Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences. Oral Oncol. 2016;61:19–26.CrossRef
9.
Zurück zum Zitat Margalit DN, Schoenfeld JD, Rawal B, Haddad RI, Catalano PJ, Goguen LA, et al. Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapy. Oral Oncol. 2017;73:160–5.CrossRef Margalit DN, Schoenfeld JD, Rawal B, Haddad RI, Catalano PJ, Goguen LA, et al. Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapy. Oral Oncol. 2017;73:160–5.CrossRef
10.
Zurück zum Zitat Tanvetyanon T, Padhya T, McCaffrey J, Zhu W, Boulware D, Deconti R, et al. Prognostic factors for survival after salvage reirradiation of head and neck cancer. J Clin Oncol. 2009;27:1983–91.CrossRef Tanvetyanon T, Padhya T, McCaffrey J, Zhu W, Boulware D, Deconti R, et al. Prognostic factors for survival after salvage reirradiation of head and neck cancer. J Clin Oncol. 2009;27:1983–91.CrossRef
11.
Zurück zum Zitat Ward MC, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, et al. Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: a multi-institution cohort study by the MIRI collaborative. Int J Radiat Oncol* Biol* Phys. 2018;100:586–94.CrossRef Ward MC, Riaz N, Caudell JJ, Dunlap NE, Isrow D, Zakem SJ, et al. Refining patient selection for reirradiation of head and neck squamous carcinoma in the IMRT era: a multi-institution cohort study by the MIRI collaborative. Int J Radiat Oncol* Biol* Phys. 2018;100:586–94.CrossRef
12.
Zurück zum Zitat Ward MC, Lee NY, Caudell JJ, Zajichek A, Awan MJ, Koyfman SA, et al. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck. Oral Oncol. 2019;90:80–6.CrossRef Ward MC, Lee NY, Caudell JJ, Zajichek A, Awan MJ, Koyfman SA, et al. A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck. Oral Oncol. 2019;90:80–6.CrossRef
13.
Zurück zum Zitat Riaz N, Hong JC, Sherman EJ, Morris L, Fury M, Ganly I, et al. A nomogram to predict loco-regional control after re-irradiation for head and neck cancer. Radiother Oncol. 2014;111:382–7.CrossRef Riaz N, Hong JC, Sherman EJ, Morris L, Fury M, Ganly I, et al. A nomogram to predict loco-regional control after re-irradiation for head and neck cancer. Radiother Oncol. 2014;111:382–7.CrossRef
14.
Zurück zum Zitat Skjøtskift T, Evensen ME, Furre T, Moan JM, Amdal CD, Bogsrud TV, et al. Dose painting for re-irradiation of head and neck cancer. Acta Oncol. 2018;57:1693–9.CrossRef Skjøtskift T, Evensen ME, Furre T, Moan JM, Amdal CD, Bogsrud TV, et al. Dose painting for re-irradiation of head and neck cancer. Acta Oncol. 2018;57:1693–9.CrossRef
15.
Zurück zum Zitat Welz S, Paulsen F, Pfannenberg C, Reimold M, Reischl G, Nikolaou K, et al. Dose escalation to hypoxic subvolumes in head and neck cancer: a randomized phase II study using dynamic [18F]FMISO PET/CT. Radiother Oncol. 2022;171:30–6.CrossRef Welz S, Paulsen F, Pfannenberg C, Reimold M, Reischl G, Nikolaou K, et al. Dose escalation to hypoxic subvolumes in head and neck cancer: a randomized phase II study using dynamic [18F]FMISO PET/CT. Radiother Oncol. 2022;171:30–6.CrossRef
16.
Zurück zum Zitat Ward MC, Koyfman SA, Bakst RL, Margalit DN, Beadle BM, Beitler JJ, et al. Retreatment of recurrent or second primary head and neck cancer after prior radiation: executive summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC): expert panel on radiation oncology—head and neck cancer. Int J Radiat Oncol Biol Phys. 2022;S0360–3016(22):00280–2. Ward MC, Koyfman SA, Bakst RL, Margalit DN, Beadle BM, Beitler JJ, et al. Retreatment of recurrent or second primary head and neck cancer after prior radiation: executive summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC): expert panel on radiation oncology—head and neck cancer. Int J Radiat Oncol Biol Phys. 2022;S0360–3016(22):00280–2.
17.
Zurück zum Zitat Zhao X, Liang Y-J, Zhang X, Wen D-X, Fan W, Tang L-Q, et al. Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2022;49:2972–82.CrossRef Zhao X, Liang Y-J, Zhang X, Wen D-X, Fan W, Tang L-Q, et al. Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2022;49:2972–82.CrossRef
18.
Zurück zum Zitat Akram F, Koh PE, Wang F, Zhou S, Tan SH, Paknezhad M, et al. Exploring MRI based radiomics analysis of intratumoral spatial heterogeneity in locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy. PLoS ONE. 2020;15:e0240043 (Woloschak GE, editor).CrossRef Akram F, Koh PE, Wang F, Zhou S, Tan SH, Paknezhad M, et al. Exploring MRI based radiomics analysis of intratumoral spatial heterogeneity in locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy. PLoS ONE. 2020;15:e0240043 (Woloschak GE, editor).CrossRef
19.
Zurück zum Zitat Yan D, Chen S, Krauss DJ, Chen PY, Chinnaiyan P, Wilson GD. Tumor voxel dose-response matrix and dose prescription function derived using 18F-FDG PET/CT images for adaptive dose painting by number. Int J Radiat Oncol* Biol* Phys. 2019;104:207–18.CrossRef Yan D, Chen S, Krauss DJ, Chen PY, Chinnaiyan P, Wilson GD. Tumor voxel dose-response matrix and dose prescription function derived using 18F-FDG PET/CT images for adaptive dose painting by number. Int J Radiat Oncol* Biol* Phys. 2019;104:207–18.CrossRef
20.
Zurück zum Zitat Beddok A, Saint-Martin C, Krhili S, Eddine CA, Champion L, Chilles A, et al. Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: outcomes and analysis of patterns of failure. Head Neck. 2022. https://doi.org/10.1002/hed.27153.CrossRef Beddok A, Saint-Martin C, Krhili S, Eddine CA, Champion L, Chilles A, et al. Curative high-dose reirradiation for patients with recurrent head and neck squamous cell carcinoma using IMRT or proton therapy: outcomes and analysis of patterns of failure. Head Neck. 2022. https://​doi.​org/​10.​1002/​hed.​27153.CrossRef
21.
Zurück zum Zitat Lau KY, Kan WK, Sze WM, Lee AWM, Chan JKW, Yau TK, et al. Magnetic resonance for T-staging of nasopharyngeal carcinoma—the most informative pair of sequences. Jpn J Clin Oncol. 2004;34:171–5.CrossRef Lau KY, Kan WK, Sze WM, Lee AWM, Chan JKW, Yau TK, et al. Magnetic resonance for T-staging of nasopharyngeal carcinoma—the most informative pair of sequences. Jpn J Clin Oncol. 2004;34:171–5.CrossRef
22.
Zurück zum Zitat Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012;30:1323–41.CrossRef Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012;30:1323–41.CrossRef
24.
Zurück zum Zitat Nioche C, Orlhac F, Boughdad S, Reuzé S, Goya-Outi J, Robert C, et al. LIFEx: A freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786–9.CrossRef Nioche C, Orlhac F, Boughdad S, Reuzé S, Goya-Outi J, Robert C, et al. LIFEx: A freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018;78:4786–9.CrossRef
25.
Zurück zum Zitat Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46:1117–26.CrossRef Dawson LA, Anzai Y, Marsh L, Martel MK, Paulino A, Ship JA, et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2000;46:1117–26.CrossRef
26.
Zurück zum Zitat Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.CrossRef Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.CrossRef
28.
Zurück zum Zitat Dionisi F, Fiorica F, D’Angelo E, Maddalo M, Giacomelli I, Tornari E, et al. Organs at risk’s tolerance and dose limits for head and neck cancer re-irradiation: a literature review. Oral Oncol. 2019;98:35–47.CrossRef Dionisi F, Fiorica F, D’Angelo E, Maddalo M, Giacomelli I, Tornari E, et al. Organs at risk’s tolerance and dose limits for head and neck cancer re-irradiation: a literature review. Oral Oncol. 2019;98:35–47.CrossRef
29.
Zurück zum Zitat Popovtzer A, Gluck I, Chepeha DB, Teknos TN, Moyer JS, Prince ME, et al. The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. Int J Radiat Oncol Biol Phys. 2009;74:1342–7.CrossRef Popovtzer A, Gluck I, Chepeha DB, Teknos TN, Moyer JS, Prince ME, et al. The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets. Int J Radiat Oncol Biol Phys. 2009;74:1342–7.CrossRef
30.
Zurück zum Zitat Chen AM, Farwell DG, Luu Q, Cheng S, Donald PJ, Purdy JA. Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011;80:669–76.CrossRef Chen AM, Farwell DG, Luu Q, Cheng S, Donald PJ, Purdy JA. Prospective trial of high-dose reirradiation using daily image guidance with intensity-modulated radiotherapy for recurrent and second primary head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2011;80:669–76.CrossRef
31.
Zurück zum Zitat Song J, Yin Y, Wang H, Chang Z, Liu Z, Cui L. A review of original articles published in the emerging field of radiomics. Eur J Radiol. 2020;127:108991.CrossRef Song J, Yin Y, Wang H, Chang Z, Liu Z, Cui L. A review of original articles published in the emerging field of radiomics. Eur J Radiol. 2020;127:108991.CrossRef
32.
Zurück zum Zitat Morin O, Vallières M, Jochems A, Woodruff HC, Valdes G, Braunstein SE, et al. A deep look into the future of quantitative imaging in oncology: a statement of working principles and proposal for change. Int J Radiat Oncol Biol Phys. 2018;102:1074–82.CrossRef Morin O, Vallières M, Jochems A, Woodruff HC, Valdes G, Braunstein SE, et al. A deep look into the future of quantitative imaging in oncology: a statement of working principles and proposal for change. Int J Radiat Oncol Biol Phys. 2018;102:1074–82.CrossRef
34.
Zurück zum Zitat Norgeot B, Quer G, Beaulieu-Jones BK, Torkamani A, Dias R, Gianfrancesco M, et al. Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist. Nat Med. 2020;26:1320–4.CrossRef Norgeot B, Quer G, Beaulieu-Jones BK, Torkamani A, Dias R, Gianfrancesco M, et al. Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist. Nat Med. 2020;26:1320–4.CrossRef
35.
Zurück zum Zitat Alfieri S, Romanò R, Bologna M, Calareso G, Corino V, Mirabile A, et al. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients. Acta Oncol. 2021;60:1192–200.CrossRef Alfieri S, Romanò R, Bologna M, Calareso G, Corino V, Mirabile A, et al. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients. Acta Oncol. 2021;60:1192–200.CrossRef
36.
Zurück zum Zitat Bogowicz M, Leijenaar RTH, Tanadini-Lang S, Riesterer O, Pruschy M, Studer G, et al. Post-radiochemotherapy PET radiomics in head and neck cancer—the influence of radiomics implementation on the reproducibility of local control tumor models. Radiother Oncol. 2017;125:385–91.CrossRef Bogowicz M, Leijenaar RTH, Tanadini-Lang S, Riesterer O, Pruschy M, Studer G, et al. Post-radiochemotherapy PET radiomics in head and neck cancer—the influence of radiomics implementation on the reproducibility of local control tumor models. Radiother Oncol. 2017;125:385–91.CrossRef
37.
Zurück zum Zitat Traylor KS, Koontz N, Mosier K. Squamous cell carcinoma: PET/CT and PET/MRI of the pretreatment and post-treatment neck. Semin Ultrasound CT MR. 2019;40:400–13.CrossRef Traylor KS, Koontz N, Mosier K. Squamous cell carcinoma: PET/CT and PET/MRI of the pretreatment and post-treatment neck. Semin Ultrasound CT MR. 2019;40:400–13.CrossRef
38.
Zurück zum Zitat Cao C, Xu Y, Huang S, Jiang F, Jin T, Jin Q, et al. Locoregional extension patterns of nasopharyngeal carcinoma detected by FDG PET/MR. Front Oncol. 2021;11:763114.CrossRef Cao C, Xu Y, Huang S, Jiang F, Jin T, Jin Q, et al. Locoregional extension patterns of nasopharyngeal carcinoma detected by FDG PET/MR. Front Oncol. 2021;11:763114.CrossRef
39.
Zurück zum Zitat Szyszko TA, Cook GJR. PET/CT and PET/MRI in head and neck malignancy. Clin Radiol. 2018;73:60–9.CrossRef Szyszko TA, Cook GJR. PET/CT and PET/MRI in head and neck malignancy. Clin Radiol. 2018;73:60–9.CrossRef
Metadaten
Titel
[18F]-FDG PET and MRI radiomic signatures to predict the risk and the location of tumor recurrence after re-irradiation in head and neck cancer
verfasst von
Arnaud Beddok
Fanny Orlhac
Valentin Calugaru
Laurence Champion
Catherine Ala Eddine
Christophe Nioche
Gilles Créhange
Irène Buvat
Publikationsdatum
25.10.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 2/2023
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-022-06000-7

Weitere Artikel der Ausgabe 2/2023

European Journal of Nuclear Medicine and Molecular Imaging 2/2023 Zur Ausgabe